BioAdvance News

Optofluidics Awarded NSF Phase IIB SBIR

By WebmasterAugust 1, 2014November 1st, 2024No Comments

Optofluidics Awarded NSF Phase IIB SBIR
Read more here

Previous PostRelmada Therapeutics, Inc. Completes Name Change and Announces New Ticker
Next PostIntezyne Technologies Expands Executive Leadership Team with Two Key Appointments